IntrinsicIntrinsic
← Scroll for more →

Recent Updates — INLX

September 18, 2026View Source ↗

Intellinetics, Inc. filed an amendment to disclose the terms of a separation agreement with former Secretary and Chief Strategy Officer Matthew Chretien, who retired effective September 1, 2026. Under the agreement executed on September 15, 2026, Mr. Chretien receives severance equal to three months' salary and will continue as an hourly consultant. Concurrently, the Board approved a title change for Joseph Spain, effective September 1, 2026, appointing him Chief Financial Officer, Secretary, and Treasurer while removing his role as Chief Operating Officer; his compensation remains unchanged. Intellinetics operates in the healthcare technology industry, providing software solutions for medical device manufacturers.

September 1, 2026View Source ↗

Intellinetics, Inc. announced that CEO Matthew Chretien will retire and resign his roles as Secretary and Chief Strategy Officer effective September 1, 2026. The company expects to enter into a separation agreement with Mr. Chretien, though material terms have not yet been determined and will be disclosed in a subsequent filing if required. Intellinetics, Inc. operates in the healthcare technology industry, providing software solutions for medical practices.